MONTREAL, 24 de marzo de 2023 /PRNewswire/ — Knight Therapeutics Inc. (TSX: GUD) (“Knight” o “la Compañía”) se complace en anunciar que ha sido incluida en la lista Women Lead Here 2023 de la revista Report on Business de The Globe and Mail. Este referente editorial anual identifica a…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.